A Randomized, Double-blind, Placebo-controlled Study of ZSP1601 in Adult Subjects With Nonalcoholic Steatohepatitis (NASH)
Clinical trial NCT05692492 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05692492
- Sponsor
- Guangdong Raynovent Biotech Co., Ltd
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-03
- Primary completion
- 2026-06-16
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.